Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Jones

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
European Urology|December 3, 2014
Making trials work in practice: please mind the gapRobert J Jones
Physiotherapy Theory and Practice|February 26, 2021
Blind and partially sighted physiotherapy in the United Kingdom. A century of development, success and challenge. Will it still belong?Robert J Jones
Oncology (Williston Park, N.Y.)|May 31, 2018
Counterpoint: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for AbirateroneRobert J Jones
European Urology|January 14, 2014
Sequencing systemic therapies in advanced prostate cancer: spoiled for choice but not for evidenceRobert J Jones
European Urology Focus|June 9, 2024
Toxicities of Novel Agents for the Treatment of Advanced Bladder CancerSamuel McInerney, Robert J Jones
Future Oncology (London, England)|October 6, 2015
Emerging treatments for recurrent prostate cancerCatherine Hanna, Robert J Jones
Breast Cancer Research : BCR|June 24, 2003
8th international conference: primary therapy of early breast cancer, St Gallen, Switzerland, March 12-15 2003Hilary Glen, Robert J Jones
Expert Review of Anticancer Therapy|July 13, 2002
Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514)Robert J Jones, Christopher J Twelves
Health Research Policy and Systems|March 12, 2021
Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessmentCatherine R Hanna, Kathleen A Boyd, Robert J Jones
Resuscitation|December 17, 2008
Cardiac arrests of hospital staff and visitors: experience from the national registry of cardiopulmonary resuscitationBruce D Adams, Robert J Jones, Roxana E Delgado, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
European Urology|December 3, 2014
Making trials work in practice: please mind the gapRobert J Jones
Physiotherapy Theory and Practice|February 26, 2021
Blind and partially sighted physiotherapy in the United Kingdom. A century of development, success and challenge. Will it still belong?Robert J Jones
Oncology (Williston Park, N.Y.)|May 31, 2018
Counterpoint: Chemotherapy vs Abiraterone for the Initial Management of Metastatic Prostate Cancer: The Case for AbirateroneRobert J Jones
European Urology|January 14, 2014
Sequencing systemic therapies in advanced prostate cancer: spoiled for choice but not for evidenceRobert J Jones
European Urology Focus|June 9, 2024
Toxicities of Novel Agents for the Treatment of Advanced Bladder CancerSamuel McInerney, Robert J Jones
Future Oncology (London, England)|October 6, 2015
Emerging treatments for recurrent prostate cancerCatherine Hanna, Robert J Jones
Breast Cancer Research : BCR|June 24, 2003
8th international conference: primary therapy of early breast cancer, St Gallen, Switzerland, March 12-15 2003Hilary Glen, Robert J Jones
Expert Review of Anticancer Therapy|July 13, 2002
Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514)Robert J Jones, Christopher J Twelves
Health Research Policy and Systems|March 12, 2021
Evaluating cancer research impact: lessons and examples from existing reviews on approaches to research impact assessmentCatherine R Hanna, Kathleen A Boyd, Robert J Jones
Resuscitation|December 17, 2008
Cardiac arrests of hospital staff and visitors: experience from the national registry of cardiopulmonary resuscitationBruce D Adams, Robert J Jones, Roxana E Delgado, et al.
Pageof 9